Kiwi Biosciences is a science-driven consumer health company pioneering enzyme-based solutions that help people better tolerate the foods they love. Our flagship product, FODZYME®, is the first targeted enzyme formula designed to break down common, hard-to-digest carbohydrates (FODMAPs), enabling millions of people with digestive sensitivities to enjoy meals with greater comfort and confidence. FODZYME® is certified low-FODMAP by Monash University and is backed by peer-reviewed scientific validation demonstrating its ability to degrade challenging carbohydrate triggers.
We are Y Combinator-backed, scaling from a seed-stage biotech startup into a rapidly growing consumer health brand with global reach. Our products have made over 12M meals painless and are available across the U.S., Europe, Australia, and New Zealand, with increasing clinician partnerships.
